Clinical Trials Directory

Trials / Completed

CompletedNCT01056705

The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV)

The Phase Ⅱ Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
500 (actual)
Sponsor
Chinese Academy of Medical Sciences · Academic / Other
Sex
All
Age
60 Days – 90 Days
Healthy volunteers
Accepted

Summary

Based on pre-clinical trial and phase 1 clinical data and principle of GCP, the objective of phase Ⅱ clinical trial is to evaluate safety and immunogenicity of Inactivated Poliomyelitis Vaccine made from Sabin Strains(Sabin IPV).

Detailed description

The Sabin IPV was manufactured with poliovirus type1, 2, 3 Sabin strains and Vero cells by microcarrier culture in 550 liter bioreactors. The virus suspension was harvested ,ultra-concentrated, purified and inactivated with formalin. Three formulations A,B,C of Sabin IPV were used, the DAg contents for A were type1 45,type2 64,type3 67.5 DU /0.5ml/per dose; for B 30,32,45 DU/0.5ml/per dose; for C 15,16,22.5 DU/0.5ml/per dose. Oral Poliomyelitis Vaccine(OPV)was manufactured by Institute of Medical Biology, Chinese Academy of Medical Sciences.Trivalent OPV contains Polioviruses Type 1 6.0 log CCID Type 2 5.0 log Type 3 5.5log /0.1ml/per dose Inactivated Poliomyelitis Vaccine (Salk strains)was manufactured by Sanofi Pasteur DAg contents /0.5ml/per dose were Type 1 40 DU,Type 2 8DU,Type 3 32DU. This is a randomized, blind phase 2 clinical trial. Total 500 infants (ages 60 days to 90 days) were selected , randomized to five groups(each group n=100) Sabin IPV formulations A,B,C,OPV ,Salk IPV were separately given to each group with three doses one month apart respectively.

Conditions

Interventions

TypeNameDescription
BIOLOGICALInactivated Poliomyelitis Vaccine (Sabin strains)Inactivated Poliomyelitis Vaccine (Sabin strains) formulation A. 3x0.5ml intramuscular injections,one month apart.
BIOLOGICALInactivated Poliomyelitis Vaccine (Sabin strains)Inactivated Poliomyelitis Vaccine (Sabin strains) formulation B. 3x0.5ml intramuscular injections, one month apart.
BIOLOGICALInactivated Poliomyelitis Vaccine (Sabin strains)Inactivated Poliomyelitis Vaccine (Sabin strains) formulation C. 3x0.5ml intramuscular injections, one month apart.
BIOLOGICALOral Poliomyelitis VaccineOral Poliomyelitis Vaccine (OPV).3x0.5mloral, one month apart.
BIOLOGICALInactivated Poliomyelitis Vaccine (Salk strains).3x0.5ml intramuscular injections, one month apart.

Timeline

Start date
2009-07-01
Primary completion
2010-05-01
Completion
2010-08-01
First posted
2010-01-26
Last updated
2016-08-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01056705. Inclusion in this directory is not an endorsement.

The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV) (NCT01056705) · Clinical Trials Directory